Pavan Cheruvu

Pavan Cheruvu is a declared insider of Sio Gene Therapies Inc. (chief executive), with filings sourced from SEC (Form 4). Between 14 June 2019 and 8 December 2021, the trades on record add up to 8 filings.

The open-market record is one-sided, with 3 purchases worth €333k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants. 2021 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €91k. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 9 December 2021, the filings show a share grant worth €19k in Sio Gene Therapies Inc. The most recent open-market purchase was published on 24 March 2021, 2,039 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.